Published in Lancet on January 09, 1999
Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut (2005) 1.93
Infection, coagulation, and variceal bleeding in cirrhosis. Gut (2005) 1.39
Gut flora and bacterial translocation in chronic liver disease. World J Gastroenterol (2006) 1.29
Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice. World J Gastroenterol (2008) 1.26
Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int (2007) 1.24
New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol (2006) 1.17
Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations. Hepatol Int (2011) 1.04
Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats. Gut (2006) 1.02
Spontaneous bacterial peritonitis: a severe complication of liver cirrhosis. World J Gastroenterol (2009) 1.01
Management of varices in patients with cirrhosis. Nat Rev Gastroenterol Hepatol (2013) 0.99
Diagnosis and management of bacterial infections in decompensated cirrhosis. World J Hepatol (2013) 0.99
The effects of cefazolin on cirrhotic patients with acute variceal hemorrhage after endoscopic interventions. Surg Endosc (2011) 0.98
Antibiotic prophylaxis using third generation cephalosporins can reduce the risk of early rebleeding in the first acute gastroesophageal variceal hemorrhage: a prospective randomized study. J Korean Med Sci (2006) 0.94
Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding. Dig Dis Sci (2001) 0.94
Microbial translocation in chronic liver diseases. Int J Microbiol (2012) 0.94
Management of portal hypertension. Postgrad Med J (2004) 0.90
Gluing gastric varices in 2012: lessons learnt over 25 years. J Clin Exp Hepatol (2012) 0.86
Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis. World J Hepatol (2014) 0.86
Serum levels of soluble Fas, nitric oxide and cytokines in acute decompensated cirrhotic patients. World J Gastroenterol (2007) 0.85
Endoscopic treatment of esophageal varices in patients with liver cirrhosis. World J Gastroenterol (2014) 0.84
Increased plasma malondialdehyde in patients with viral cirrhosis and its relationships to plasma nitric oxide, endotoxin, and portal pressure. Dig Dis Sci (2009) 0.83
Probiotics in hepatology. World J Gastroenterol (2011) 0.82
Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications. World J Hepatol (2015) 0.82
Acute variceal bleeding: general management. World J Gastroenterol (2001) 0.81
A case of bacteremia by Neisseria gonorrhoeae coincident with massive hemorrhage of esophageal varices. Korean J Lab Med (2011) 0.80
Recurrent bacteremia, a complication of cyanoacrylate injection for variceal bleeding: report of two cases and review of the literature. Case Rep Med (2009) 0.79
Current research of hepatic cirrhosis in China. World J Gastroenterol (2005) 0.79
Endogenous heparinoids in acute variceal bleeding. Gut (2005) 0.79
Primary prevention of variceal bleeding: pharmacological therapy versus endoscopic banding. N Am J Med Sci (2013) 0.78
Management of acute variceal bleeding. Clin Endosc (2014) 0.78
Hepatosplanchnic circulation in cirrhosis and sepsis. World J Gastroenterol (2015) 0.78
A retrospective study of bacterial infections in cirrhosis. Maedica (Buchar) (2011) 0.77
Effect of endotoxin on portal hemodynamic in rats. World J Gastroenterol (2002) 0.77
Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis? Clin Mol Hepatol (2012) 0.76
Spontaneous bleeding or thrombosis in cirrhosis: What should be feared the most? World J Hepatol (2015) 0.76
Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis. Dig Dis Sci (2016) 0.75
Prognostic factors associated with mortality in patients with gastric fundal variceal bleeding. World J Gastroenterol (2017) 0.75
Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the disease. BMC Gastroenterol (2015) 0.75
Selective Intestinal Decontamination in Portal Hypertension. Gastroenterol Hepatol (N Y) (2006) 0.75
Future therapy of portal hypertension in liver cirrhosis - a guess. F1000Prime Rep (2014) 0.75
Towards noninvasive detection of oesophageal varices. Int J Hepatol (2012) 0.75
Antibiotic prophylaxis in the prevention of rebleeding in acute variceal hemorrhage: A randomized trial. J Pharmacol Pharmacother (2015) 0.75
Clinical implications of Paracoccus yeeii bacteremia in a patient with decompensated cirrhosis. IDCases (2016) 0.75
Increased serum activity of matrix metalloproteinase-9 in patients with acute variceal bleeding. Gut Liver (2012) 0.75
Effect of alternative antibiotics in treatment of cefotaxime resistant spontaneous bacterial peritonitis. World J Gastroenterol (2013) 0.75
Endotoxaemia, hyperfibrinolysis, and bleeding in cirrhosis. Lancet (1999) 0.75
Liver: Can pentoxifylline secure its place in liver therapeutics? Nat Rev Gastroenterol Hepatol (2010) 0.75
Circadian pattern of acute variceal bleeding among cirrhotic Egyptian patients. Indian J Hematol Blood Transfus (2009) 0.75
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Carcinoid tumour. Lancet (1998) 4.52
Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort. Aliment Pharmacol Ther (2014) 3.98
Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev (2007) 2.75
Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol (2010) 2.50
Anti-tuberculosis medication and the liver: dangers and recommendations in management. Eur Respir J (1995) 2.39
The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant (2012) 2.29
An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye. Endoscopy (2006) 2.22
Coagulation and fibrosis in chronic liver disease. Gut (2008) 2.22
Systematic review and meta-analysis of intraoperative versus preoperative endoscopic sphincterotomy in patients with gallbladder and suspected common bile duct stones. Br J Surg (2011) 2.13
Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med (1983) 2.10
Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther (2006) 2.00
Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet (1999) 1.98
"Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology (1998) 1.95
Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut (2005) 1.93
Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scand J Gastroenterol (2002) 1.92
A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology (2002) 1.90
An appraisal of the histopathological assessment of liver fibrosis. Gut (2006) 1.87
Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther (2005) 1.86
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet (1996) 1.78
A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol (1999) 1.76
Change in occurrence of paracetamol overdose in UK after introduction of blister packs. Lancet (2000) 1.75
Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74
Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med (1992) 1.72
Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut (1998) 1.63
Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev (2006) 1.63
Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost (2010) 1.62
Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut (2006) 1.61
Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? Am J Gastroenterol (1999) 1.60
The costimulatory genes Cd80 and Cd86 are linked on mouse chromosome 16 and human chromosome 3. Mamm Genome (1997) 1.59
Review article: portal vein thrombosis -- new insights into aetiology and management. Aliment Pharmacol Ther (2005) 1.59
Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology (1998) 1.57
Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort study. Aliment Pharmacol Ther (2013) 1.56
Azathioprine in liver transplantation: a reevaluation of its use and a comparison with mycophenolate mofetil. Am J Transplant (2009) 1.52
Diurnal pattern of variceal bleeding in cirrhotic patients. J Hepatol (1993) 1.47
Randomized controlled trial of tacrolimus versus microemulsified cyclosporin (TMC) in liver transplantation: poststudy surveillance to 3 years. Am J Transplant (2006) 1.47
Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis. Aliment Pharmacol Ther (2011) 1.46
Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther (2007) 1.45
Tacrolimus exposure after liver transplantation in randomized controlled trials: too much for too long. Am J Transplant (2013) 1.40
Systematic review of radiological imaging for hepatocellular carcinoma in cirrhotic patients. Br J Radiol (2004) 1.40
Infection, coagulation, and variceal bleeding in cirrhosis. Gut (2005) 1.39
Staple-line erosion: a common source of recurrent bleeding following stapled oesophageal transection. Br J Surg (1991) 1.39
Who's for tips? Clin Radiol (1995) 1.38
Ultrasound screening for hepatocellular carcinoma (HCC) in cirrhosis: the evidence for an established clinical practice. Clin Radiol (1998) 1.38
LeVeen shunt with wandering tip. Lancet (1991) 1.36
Idiopathic acute fatty liver of pregnancy in 12 patients. Q J Med (1982) 1.36
Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir. J Infect Dis (2004) 1.35
Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther (2009) 1.35
Controversies in the management of bleeding esophageal varices (1) N Engl J Med (1989) 1.30
Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis. Hepatology (1999) 1.29
Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol (1992) 1.27
Female liver transplant recipients with the same GFR as male recipients have lower MELD scores--a systematic bias. Am J Transplant (2007) 1.25
Endoscopic extraction of bile duct stones: management related to stone size. Gut (1993) 1.24
Bacteriuria and primary biliary cirrhosis. Gut (1984) 1.20
Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy. Am J Transplant (2012) 1.19
Donor-specific bone marrow infusion after orthotopic liver transplantation. Lancet (1994) 1.18
A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma. Br J Cancer (2013) 1.17
Review article: scoring systems for assessing prognosis in critically ill adult cirrhotics. Aliment Pharmacol Ther (2006) 1.17
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther (2006) 1.15
Hepatic artery thrombosis after orthotopic liver transplantation: a review of nonsurgical causes. Liver Transpl (2001) 1.15
Should we biopsy each liver mass suspicious for HCC before liver transplantation?--no, please don't. J Hepatol (2005) 1.15
Controversies in the management of bleeding esophageal varices (2) N Engl J Med (1989) 1.14
Distal spleno-renal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. A meta-analysis of 4 randomized clinical trials. J Hepatol (1992) 1.14
Treatment of small hepatocellular carcinomas. Lancet (1992) 1.13
In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver (1997) 1.13
Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology (1995) 1.11
Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies. J Viral Hepat (2008) 1.11
Bleeding time in patients with hepatic cirrhosis. BMJ (1990) 1.10
Hepatocellular ballooning after liver transplantation: a light and electronmicroscopic study with clinicopathological correlation. Histopathology (1991) 1.10
Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol (1997) 1.10
Why portal hypertensive varices bleed and bleed: a hypothesis. Gut (1995) 1.10
Molecular mimicry in liver disease. Nature (1992) 1.10
Reducing early exposure to calcineurin inhibitors: the key factor for a successful renal sparing strategy. Am J Transplant (2012) 1.09
Disopyramide and warfarin interaction. Br Med J (1977) 1.09
Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. J Immunol (1998) 1.09
The impact of hepatitis C in general practice. Br J Gen Pract (2000) 1.08
Long-standing asymptomatic primary sclerosing cholangitis: report of three cases. Dig Dis Sci (1981) 1.08
M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria. J Hepatol (1993) 1.07
Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. Lancet (1999) 1.07
Nutritional status and prognosis in cirrhotic patients. Aliment Pharmacol Ther (2006) 1.06